Syk-IN-4 (C007B-419231)

Syk-IN-4 is a potent, selective and orally bioavailable SYK inhibitor with an IC 50 of 0.31 nM. SYK has emerged as a potential target for autoimmunity and hematological cancers.Appearance:SolidIC50& Target:IC50: 0.31 nM (SYK)In Vitro:Syk-IN-4 is a potent inhibitor of hERG with an IC 50 of 3.0 μM. Syk-IN-4 inhibits SUDHL-4 and T cell proliferation with GI 50 s of 0.24 and 2.6 µM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for refIn Vivo:Syk-IN-4 exhibits moderate oral bioavailability (60%) following oral administration (1mg/kg) in male Hans Wistar rats. Syk-IN-4 exhibits high plasma clearance (151 mL/min/kg) combined with large volumes of distribution (1.0 L/kg respectively) followBiological Activity:Syk-IN-4 is a potent, selective and orally bioavailable SYK inhibitor with an IC 50 of 0.31 nM. SYK has emerged as a potential target for autoimmunity and hematological cancers.

Specifications and Purity: ≥98%

Molecular Formula: C21H25N9O

Molecular Weight: 419.48